Ixoreal Biomed Inc – USA Address
1039 Selby Ave., Los Angeles, CA 90024
Phone: (310) 424-5535
E-mail: [email protected]

Ixoreal Biomed Inc – India Address
Plot No-1057-F2, PBN Center, Rd. No. 45
Jubilee Hills, Hyderabad-500033
Telangana, India
Phone: +91-40-2355-4386

Ixoreal Biomed is a research-driven nutraceutical and botanical ingredient company headquartered in Los Angeles, CA, with operations in Hyderabad, India. At its core, the company is on a mission to bridge the ancient wisdom of ayurveda with the rigor of modern science, backing every product with deep research, robust clinical studies and a relentless focus on sustainable development.

The company is globally recognized for its clinically studied botanical extracts, including the flagship KSM-66 Ashwagandha and SRI-81 Shatavari, both of which have earned the trust of formulators and consumers worldwide. What sets Ixoreal apart is its end-to-end control over quality. From responsible sourcing and vertically integrated supply chains to advanced scientific technologies and green chemistry practices, every step is designed to deliver high-quality, evidence-based herbal ingredients. These ingredients power dietary supplements, functional foods, beverages and wellness applications across the globe, making Ixoreal a partner of choice for brands that refuse to compromise on science, sustainability or efficacy.

A visionary business leader with 25-plus years of senior executive experience across 25-plus countries, Paras Kumar Jain, Ixoreal Biomed’s group chief operating officer has a track record of turning ambitious visions into market-leading realities. A leader who thrives on building from the ground up, he brings a rare blend of operational rigor, global brand-building mastery and an unwavering commitment to governance and excellence. These are strengths that transcend industries and create impact wherever they are applied. Leading from the extracts space, he operates at the very foundation of the global wellness and nutrition value chain. Without high-quality, clinically validated extracts, there is no credible finished product. Jain understands this deeply and has made it his mission to elevate the science, sustainability and commercial strength of botanical extracts on a global stage.

NIE: What is SRI-81 Shatavari? What are some of the benefits?

Jain: SRI-81 Shatavari is a standardized, organic, root only extract of shatavari (Asparagus racemosus) built for clinical grade consistency and efficacy. Ayurveda calls shatavari the “Queen of Herbs” and we have made it our business to prove why.

The benefits are compelling:

• Hormonal balance and reproductive health

• Stress reduction, better mood and improved sleep

• Enhanced libido and sexual vitality

• Lactation support and postpartum recovery

• Relief from hot flashes, night sweats and menopausal discomfort

Every single one of these is being clinically validated. We did not enter this space to make claims. We entered to set the standard.

NIE: Please discuss SRI-81’s recent studies.

Jain: You cannot lead a category on the back of tradition alone. SRI-81 Shatavari today is backed by around 18 clinical studies: five published, four completed and nine ongoing across perimenopause, menopause, hormonal regulation, lactation and sexual function. The published data speaks for itself:

Postpartum Lactation: At 300 mg/day, significant enhancement in lactation within 72 hours, with faster breast fullness, increased milk volume and improved maternal wellbeing.

Menopausal Symptoms: A ~44.7 percent decrease in total Menopause Rating Scale scores, with clear improvements in stress, hot flashes and quality of life.

Perimenopausal Symptoms: A ~42.6 percent reduction in total symptom scores, with reduced stress, fewer hot flashes and increased estradiol levels.

Sexual Function in Women: A ~34.2 percent improvement in FSFI scores, with reduced sexual distress and stronger hormonal balance.

PCOS Management: A ~28.6 percent reduction in follicle count with improved reproductive parameters and lower stress levels.

This is not one study showing a marginal outcome. This is a body of evidence building across multiple dimensions of women’s health. That is how you earn the trust of formulators and consumers alike.

NIE: Ixoreal Biomed recently adopted Shatavari through the American Botanical Council’s (ABC) Adopt-an-Herb Program. Why did the company decide to take part in the program?

Jain: Shatavari has been vastly underrepresented in global scientific literature relative to its potential. We saw that as both a gap and an opportunity. By adopting shatavari through ABC’s program, we are making sure that credible, current scientific data on this herb is available to researchers, health care professionals and the industry at large. When you are the market leader in a category, you have a responsibility to elevate the entire ecosystem, not just your own brand.

NIE: Please discuss Ixoreal Biomed’s sustainability efforts.

Jain: Sustainability is not a program we run. It is how we are built. Vertically integrated cultivation, fully traceable supply chains, organic farming and green chemistry extraction processes. We control the entire value chain because quality and sustainability cannot be outsourced. And beyond operations, we invest in the farming communities that make this possible. You cannot build a lasting business by extracting value from the ground without putting something back.

NIE: Is there anything else you would like to add?

Jain: Shatavari has extraordinary potential that the global market is only beginning to understand. We are not waiting for that awareness to build on its own. Through SRI-81 Shatavari, we are actively shaping the narrative with science, sustainability and scale. Our vision is clear: make Shatavari a globally recognized, evidence-based ingredient for modern women’s health while honoring its ayurvedic roots.